Can chemo wake up immunotherapy? new hope for melanoma patients
NCT ID NCT04225390
First seen Feb 14, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tested whether giving a chemotherapy drug (dacarbazine) before immunotherapy can help patients with advanced melanoma who did not respond to standard immunotherapy. 38 adults with a specific type of melanoma (BRAF wildtype) that had stopped responding to treatment were enrolled. The goal was to see if this approach could shrink tumors or stop them from growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital
Erlangen, Bavaria, 91054, Germany
Conditions
Explore the condition pages connected to this study.